MedPath

Assessment of the test characteristics of an instant anti-CCP2 test compared to the anti-CCP2 elisa in serum

Conditions
arthritis
Reumatoid Arthritis
10013361
Registration Number
NL-OMON30010
Lead Sponsor
Sint Maartenskliniek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Rheumatoid arthritis
informed consent given
Aerea of Nijmegen
Previous Anti-CCP2 status determined

Exclusion Criteria

none

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath